Low uptake of pharmaceuticals in edible mushrooms grown in polluted biogas digestate

Astrid S. Nesse,Agnieszka Jasinska,Ketil Stoknes,Stine Göransson Aanrud,Kristin Ogner Risinggård,Roland Kallenborn,Trine A. Sogn,Aasim M. Ali
DOI: https://doi.org/10.1016/j.chemosphere.2024.141169
IF: 8.8
2024-01-29
Chemosphere
Abstract:The uptake dynamics of two sulfonamide antibiotics, two fluoroquinolone antibiotics, and the anticonvulsant carbamazepine during the cultivation of two species of edible mushrooms ( Agaricus subrufescens and A. bisporus ) was investigated. None of the antibiotics were accumulated by the mushrooms, while carbamazepine and its transformation product carbamazepine-10,11-epoxide were taken up by A. bisporus fruiting body but only in small amounts (up to 0.76 and 1.85 μg kg −1 dry weight, respectively). The sulfonamides were quickly removed from the mushroom growth substrate, while the recalcitrant fluoroquinolones and carbamazepine were only partially removed. Dissipation half-lives were generally lower for A. subrufescens than A. bisporus , but A. subrufescens was also grown at a slightly higher culture temperature. A. subrufescens also showed a lower uptake of contaminants. Comparison of maximum dietary intake with other common exposure sources showed that these mushrooms can safely be eaten although produced on a polluted substrate, with respect to the investigated compounds.
environmental sciences
What problem does this paper attempt to address?